Part of The Mesothelioma Center. Contact Us
Mesothelioma-Line.com.
Journal Articles on Mesothelioma: Cancer Information for Patients and Families

Archive for November, 2008

Newer Headlines »

November 8th, 2008. The CREST biorepository: a tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases

Conclusions: The CREST biorepository is a valuable tool for molecular epidemiology and translational studies. This structure relies on a network of contacts with local health districts that allows for an active search for patients. This is a particularly efficient approach, especially when the object of the study is a rare cancer type. The CREST experience suggests that the presence of limited resources can be overcome by the biorepository specialization, the high quality of the epidemiologic information, and the variety of samples.
Posted in Epidemiological, Full Archive, General, Type of Assessment: | No Comments »

November 6th, 2008. Benign mesothelioma of peritoneum presenting as a pelvic mass

Postoperative recovery was satisfactory. At 3 years follow-up, patient is symptom-free.
Posted in Benign, Case Study, Full Archive, Surgery, Treatment, Type of Assessment:, Type of Mesothelioma: | 1 Comment »

November 5th, 2008. Malignant mesothelioma of the tunica vaginalis: a case report

The patient has not received additional therapy because there has been no evidence of metastasis. He has been free of disease 3 months postoperatively.
Posted in Case Study, Full Archive, Surgery, Survival, Treatment, Tunica Vaginalis Testis, Type of Assessment:, Type of Mesothelioma: | No Comments »

November 5th, 2008. Case of malignant mesothelioma presenting as a perineal and intrascrotal mass

The patient died six months after the initiation of therapy. To our knowledge, 24 cases of malignant mesothelioma in the perineum or intrascrotum were reported in Japan and this case was thought to be the 25th case in Japan.
Posted in Case Study, Determining Efficacy, Full Archive, Radiation, Surgery, Survival, Treatment, Tunica Vaginalis Testis, Type of Assessment:, Type of Mesothelioma: | No Comments »

November 5th, 2008. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma

Conclusions: Cytoreductive surgery combined with intraperitoneal chemotherapy appears to be the optimal treatment for selected patients with peritoneal mesothelioma. Increased familiarity with this condition's presentation and natural history, and knowledge of available treatment options, will hopefully facilitate treatment of these patients and expedite speedy referral to appropriate treatment centres.
Posted in Chemotherapy, Determining Efficacy, Full Archive, Intraperitoneal Chemotherapy, Peritoneal (Abdominal Mesothelioma), Surgery, Survival, Treatment, Tumor Debulking, Type of Assessment:, Type of Mesothelioma: | No Comments »

November 5th, 2008. Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancer

Conclusion: In conclusion, SMRP add limited information to the diagnosis of MPM. Nevertheless, SMRP might be a useful measure in treatment and monitoring of MPM. The prognostic impact of SMRP in MPM is not conclusive and needs further evaluation.
Posted in Diagnosis & Differentiation, Full Archive, Serum Marker/Blood Test, Staging, Survival, Type of Assessment: | No Comments »

November 5th, 2008. Treatment of malignant pleural mesothelioma with carboplatin, liposomized doxorubicin, and gemcitabine: a phase II study

Conclusion: The treatment yields good results with a high number of responses and long survival, and a low toxicity. The long survival of the epitheloid subgroup with good prognostic factors is as good as or even better than some studies on radical surgery or multimodal treatment, underlining the need of randomized studies to evaluate such treatment options.
Posted in Carboplatin, Chemotherapy, Determining Efficacy, Doxorubicin, Epithelioid, Full Archive, Gemcitabine (Gemzar), Surgery, Survival, Treatment, Type of Assessment:, Type of Mesothelioma: | No Comments »

November 5th, 2008. Polyneuropathy in a patient with malignant pleural mesothelioma: a paraneoplastic syndrome

The patient was treated with immunoglobulin and prednisolone, and this resulted in subjective, objective, and paraclinical improvement of the symptoms. We therefore suggest that polyneuropathy is a possible paraneoplastic syndrome in MPM.
Posted in Case Study, Full Archive, Pleural, Symptoms & Symptom Management, Type of Assessment:, Type of Mesothelioma: | No Comments »

November 1st, 2008. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis

5% of malignant mesothelioma versus 92. 5% of adenocarcinoma.
Posted in Benign, Diagnosis & Differentiation, Full Archive, Type of Assessment:, Type of Mesothelioma: | No Comments »

November 1st, 2008. Genomic events associated with progression of pleural malignant mesothelioma

Imbalances seen by ROMA were confirmed by Affymetrix genome analysis in a subset of samples. © 2008 Wiley-Liss, Inc.
Posted in Full Archive, Gene Therapy, Pleural, Survival, Type of Assessment:, Type of Mesothelioma: | No Comments »
Newer Headlines »
Goldberg, Persky & White, P.C. Mesothelioma Lawyers